Search Results - "Shaver, Aaron C."

Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization by Seegmiller, Adam C., Kim, Annette S., Mosse, Claudio A., Shaver, , Aaron C., Thompson, Mary Ann, Li, Shaoying, Head, David R., Zutter, Mary M.

“…Objectives: To determine the effect of iterative refinement of standard ordering protocols on test utilization and results for bone marrow biopsy specimens…”
Get full text

Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics by Shaver, Aaron C., Seegmiller, Adam C.

“…Morphologic dysplasia is an important factor in diagnosis of myelodysplastic syndrome (MDS). However, the role of dysplasia is changing as new molecular…”
Get full text

Educational Case: AA Amyloidosis Complicating Common Variable Immunodeficiency by Kapp, Meghan E., Lusco, Mark A., Shaver, Aaron C.

“…The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for…”
Get full text

COVID monoclonal antibody therapy detected by serum immunofixation electrophoresis by Shaver, Aaron C., Mason, Emily F.

Get full text

Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndrome by Allison, Devin R., Dholaria, Bhagirathbhai, Kishtagari, Ashwin, Mohan, Sanjay, Steigelfest, Eli, Shaver, Aaron C., Mason, Emily F.

Get full text

Flow Cytometric Assessment of Malignant Hematologic Disorders by Hartzell, Connor M., Shaver, Aaron C., Mason, Emily F.

“…Multiparameter flow cytometry (MPF) is an essential component of the diagnostic workup of hematologic malignancies. Recently developed tools have expanded the…”
Get full text

Fitness Evolution and the Rise of Mutator Alleles in Experimental Escherichia coli Populations by Shaver, Aaron C, Dombrowski, Peter G, Sweeney, Joseph Y, Treis, Tania, Zappala, Renata M, Sniegowski, Paul D

“…We studied the evolution of high mutation rates and the evolution of fitness in three experimental populations of Escherichia coli adapting to a…”
Get full text

Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1 by Wright, Martha F., Pozdnyakova, Olga, Hasserjian, Robert P., Aggarwal, Nidhi, Shaver, Aaron C., Weinberg, Olga K., Irlmeier, Rebecca, Koyama, Tatsuki, Seegmiller, Adam C., Strickland, Stephen A., Mason, Emily F.

Get full text

Spontaneously Arising mutL Mutators in Evolving Escherichia coli Populations Are the Result of Changes in Repeat Length by Shaver, Aaron C, Sniegowski, Paul D

“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

An Incidental Hypervascular Retroperitoneal Mass by Costacurta, Patricia W, Shaver, Aaron C, Idrees, Kamran

Get more information

B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis by Shaver, Aaron C., Seegmiller, Adam C.

“…Among the most thoroughly evaluated modalities for assessment of minimal residual disease (MRD) in B acute lymphoblastic leukemia is multiparameter flow…”
Get full text

B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model by Shaver, Aaron C, Greig, Bruce W, Mosse, Claudio A, Seegmiller, Adam C

“…Optimizing a clinical flow cytometry panel can be a subjective process dependent on experience. We develop a quantitative method to make this process more…”
Get full text

Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up by Wheeler, Ferrin C, Kim, Annette S, Mosse, Claudio A, Shaver, Aaron C, Yenamandra, Ashwini, Seegmiller, Adam C

“…Abstract Objectives Acute myeloid leukemia (AML) is classified in part by recurrent cytogenetic abnormalities, often detected by both fluorescent in situ…”
Get full text

Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome by Turner, Scott A., Shaver, Aaron C., Kovach, Alexandra E., Oluwole, Olalekan O., Mason, Emily F.

Get full text

Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies by Fischer, Melissa A., Friedlander, Sharon Y., Arrate, Maria P., Chang, Hua, Gorska, Agnieszka E., Fuller, Londa D., Ramsey, Haley E., Kashyap, Trinayan, Argueta, Christian, Debler, Sophie, Byrne, Michael, Villaume, Matthew T., Shaver, Aaron C., Senapedis, William, Landesman, Yosef, Baloglu, Erkan, Shacham, Sharon, Savona, Michael R.

“…The selective inhibitor of nuclear export (SINE) compounds selinexor (KPT-330) and eltanexor (KPT-8602) are from a novel class of small molecules that target…”
Get full text

A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters by Keeney, Michael, Wood, Brent L., Hedley, Benjamin D., DiGiuseppe, Joseph A., Stetler‐Stevenson, Maryalice, Paietta, Elisabeth, Lozanski, Gerard, Seegmiller, Adam C., Greig, Bruce W., Shaver, Aaron C., Mukundan, Lata, Higley, Howard R., Sigman, Caroline C., Kelloff, Gary, Jessup, J. Milburn, Borowitz, Michael J.

“…Background Minimal residual disease (MRD) in B lymphoblastic leukemia (B‐ALL) by flow cytometry is an established prognostic factor used to adjust treatment in…”
Get full text

Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy by Cohen, Daniel N, Lawson, Steven K, Shaver, Aaron C, Du, Liping, Nguyen, Harrison P, He, Qin, Johnson, Douglas B, Lumbang, Wilfred A, Moody, Brent R, Prescott, James L, Chandra, Pranil K, Boyd, Alan S, Zwerner, Jeffrey P, Robbins, Jason B, Tyring, Stephen K, Rady, Peter L, Chappell, James D, Shyr, Yu, Infante, Jeffrey R, Sosman, Jeffrey A

“…BRAF-inhibition (BRAFi) therapy for advanced melanoma carries a high rate of secondary cutaneous squamous cell carcinoma (cSCC) and risk of other cancers. UV…”
Get full text

Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia by Strickland, Stephen A., Shaver, Aaron C., Byrne, Michael, Daber, Robert D., Ferrell, P. Brent, Head, David R., Mohan, Sanjay R., Mosse, Claudio A., Moyo, Tamara K., Stricker, Thomas P., Vnencak-Jones, Cindy, Savona, Michael R., Seegmiller, Adam C.

“…•This study identified differences in the characteristics of favorable-risk AML.•AML with normal karyotype and NPM1 mutations is distinct in age and…”
Get full text

Lymphoma and the Kidney: A Kidney Biopsy Teaching Case by L’Imperio, Vincenzo, Rossi, Mattia, Abdul, Afu, Mehta, Satyen R., Shaver, Aaron C., Fogo, Agnes B.

“…Lymphomatous infiltration of kidney parenchyma is a frequent complication of systemic hematologic malignancies and often shows subtle clinical presentation…”
Get full text

Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidation by Pham, Ly, Komalavilas, Padmini, Eddie, Alex M., Thayer, Timothy E., Greenwood, Dalton L., Liu, Ken H., Weinberg, Jaclyn, Patterson, Andrew, Fessel, Joshua P., Boyd, Kelli L., Schafer, Jenny C., Kuck, Jamie L., Shaver, Aaron C., Flaherty, David K., Matlock, Brittany K., Wijers, Christiaan D. M., Serezani, C. Henrique, Jones, Dean P., Brittain, Evan L., Rathmell, Jeffrey C., Noto, Michael J.

“…Cellular metabolism influences immune cell function, with mitochondrial fatty acid β-oxidation and oxidative phosphorylation required for multiple immune cell…”
Get full text